Novavax developing vaccine that targets new COVID-19 variant
The company has said it is on track to file for US approval by the end of the year. It has also filed for approvals with the European Medicines Agency as well as in Canada.
A woman holds a small bottle labeled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in front of displayed Novavax logo in this illustration taken, October 30, 2020.(photo credit: REUTERS/DADO RUVIC)ByREUTERS
